Severe COVID-19-associated myocarditis with cardiogenic shock - management with assist devices - a case report & review.

BMC Anesthesiol

Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.

Published: December 2022

Background: Primary viral myocarditis associated with severe acute respiratory syndrome coronavirus 2 (SARS-Cov2) infection is a rare diagnosis.

Case Presentation: We report the case of an unvaccinated, healthy patient with cardiogenic shock in the context of a COVID-19-associated myocarditis and therapy with simultaneous veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous left ventricular decompression therapy with an Impella. The aim of this review is to provide an overview of therapeutic options for patients with COVID-19-associated myocarditis.

Conclusions: The majority of patients required a combination of two assist devices to achieve sufficient cardiac output until recovery of left ventricular ejection fraction. Due to the rapid onset of this fulminant cardiogenic shock immediate invasive bridging therapy in a specialized center was lifesaving.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9742039PMC
http://dx.doi.org/10.1186/s12871-022-01890-4DOI Listing

Publication Analysis

Top Keywords

cardiogenic shock
12
covid-19-associated myocarditis
8
assist devices
8
left ventricular
8
severe covid-19-associated
4
myocarditis cardiogenic
4
shock management
4
management assist
4
devices case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!